Año 2016 / Volumen 108 / Número 11
Original
A single institution’s 21-year experience with surgically resected pancreatic neuroendocrine tumors: an analysis of survival and prognostic factors

689-696

DOI: 10.17235/reed.2016.4323/2016

Javier A. Cienfuegos, Fernando Rotellar, Joseba Salguero, Miguel Ruiz-Canela, Jorge M. Núñez Córdoba, Iosu Sola, Alberto Benito, Pablo Martí-Cruchaga, Gabriel Zozaya, Fernando Pardo, José Luis Hernández Lizoáin,

Resumen
Background: Pancreatic neuroendocrine tumors (pNETs) comprise a heterogeneous group of tumors with a varied biological behavior. In the present study, we analyzed the experience of 79 pNETs resected between 1999 and 2014. The pathologic prognostic factors (European Neuroendocrine Tumor Society, ENETS; and AJCC) classification, vascular invasion (VI), proliferation index (ki-67) and the presence of necrosis were retrospectively reviewed. Methods: The clinical data of 79 patients with pNETs who underwent surgery were retrospectively analyzed. Mortality rates and Kaplan-Meier estimates were used to evaluate survival over time for pathologic stages, tumor functionality, and vascular invasion. Cox proportional hazards models were used to calculate the hazard ratio regarding ENETS, AJCC staging, sex, tumor functionality and vascular invasion. Results: The male:female ratio was 40:39. Twenty-one patients (26%) had functional tumors and 58 (73.4%) had non-functional tumors, of which 35 (44.3%) were diagnosed incidentally. Seventeen Whipple procedures, 46 distal pancreatectomies (including 26 laparoscopic and 20 open procedures), 8 laparoscopic central pancreatectomies, 1 laparoscopic resection of the uncinated process and 7 enucleations (one laparoscopic) were performed. Vascular invasion and necrosis were observed in 29 of 75 cases (38.6%) and in 16 cases (29%), respectively. The comparison between survivor functions of ENETS staging categories showed statistically significant differences (p = 0.042). Mortality rate was higher in patients with non-functioning tumors compared with hormonally functioning tumors (p = 0.052) and in those with vascular invasion (p = 0.186). Conclusions: In spite of the heterogeneity of pNETs, the ENETS TNM classification efficiently predicts long-term prognosis. The non-functioning tumors and the presence of vascular invasion are associated with poor prognosis.
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Halperin DM, Kulke MH, Yao JC. A tale of two tumors: Treating pancreatic and extrapancreatic neuroendocrine tumors. Annu Rev Med. 2015;66:1-16.
2. Kondo NI, Ikeda Y. Practical management and treatment of pancreatic neuroendocrine tumors. Gland Surg. 2014;3:276-83.
3. Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: New insights. Nat Rev Endocrinol. 2011;8:54-64.
4. Klimstra DS, Modlin IR, Adsay NV, et al. Pathology reporting of neuroendocrine tumors: Application of the delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol. 2010;34:300-13.
5. Kloppel G, Rindi G, Perren A, et al. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: A statement. Virchows Arch. 2010;456:595-7.
6. Rindi G, Falconi M, Klersy C, et al. TNM staging of neoplasms of the endocrine pancreas: Results from a large international cohort study. J Natl Cancer Inst. 2012;104:764-77.
7. Ellison TA, Wolfgang CL, Shi C, et al. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: A validation of current staging systems and a new prognostic nomogram. Ann Surg. 2014;259:204-12.
8. Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel american joint committee on cancer staging classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011;29:3044-9.
9. Cherenfant J, Stocker SJ, Gage MK, et al. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2013;154:785,91; discussion 791-3.
10. Rotellar F, Pardo F, Montiel C, et al. Totally laparoscopic roux-en-Y duct-to-mucosa pancreaticojejunostomy after middle pancreatectomy: A consecutive nine-case series at a single institution. Ann Surg. 2008;247:938-44.
11. Rotellar F, Pardo F, Benito A, et al. Laparoscopic resection of the uncinate process of the pancreas: The inframesocolic approach and hanging maneuver of the mesenteric root. Surg Endosc. 2011;25:3426-7.
12. Rotellar F, Pardo F, Cervera M, et al. Laparoscopic distal pancreatectomy with or without splenectomy. surgical technique. Surg Endosc. 2006;20 Suppl 1:S245.
13. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery. 2005;138:8-13.
14. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): An international study group of pancreatic surgery (ISGPS) definition. Surgery. 2007;142:20-5.
15. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the international study group of pancreatic surgery (ISGPS). Surgery. 2007;142:761-8.
16. American Diabetes Association. (2) classification and diagnosis of diabetes. Diabetes Care. 2015;38 Suppl:S8-S16.
17. Klimstra D, Arnold R, Capella C, et al. Neuroendocrine neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban R, Theise ND, eds. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer, 2010. 322-6.
18. Eads JR, Meropol NJ. A new era for the systemic therapy of neuroendocrine tumors. Oncologist. 2012;17:326-38.
19. Strosberg JR, Weber JM, Feldman M, et al. Prognostic validity of the american joint committee on cancer staging classification for midgut neuroendocrine tumors. J Clin Oncol. 2013;31:420-5.
20. Birnbaum DJ, Turrini O, Ewald J, et al. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival. Eur J Surg Oncol. 2014;40:1564-71.
21. Han X, Xu X, Jin D, et al. Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: A retrospective study of 104 cases in a single chinese center. Pancreas. 2014;43:526-31.
22. Varas M, Gornals J, Ponseti JM, et al. Pancreatic endocrine tumors or apudomas. Rev Esp Enferm Dig. 2011;103:184-90.
23. Abu Hilal M, Takhar AS. Laparoscopic left pancreatectomy: Current concepts. Pancreatology. 2013;13:443-8.
24. Venkat R, Edil BH, Schulick RD, et al. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: A systematic review and meta-analysis. Ann Surg. 2012;255:1048-59.
25. Iacono C, Verlato G, Ruzzenente A, et al. Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. Br J Surg. 2013;100:873-85.
26. Pericleous S, Middleton N, McKay SC, et al. Systematic review and meta-analysis of case-matched studies comparing open and laparoscopic distal pancreatectomy: Is it a safe procedure? Pancreas. 2012;41:993-1000.
27. Huttner FJ, Koessler-Ebs J, Hackert T, et al. Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg. 2015; 102: 1026-1036.
28. Tien YW, Liu KL, Hu RH, et al. Risk of varices bleeding after spleen-preserving distal pancreatectomy with excision of splenic artery and vein. Ann Surg Oncol. 2010;17:2193-8.
29. Yoon YS, Lee KH, Han HS, et al. Patency of splenic vessels after laparoscopic spleen and splenic vessel-preserving distal pancreatectomy. Br J Surg. 2009;96:633-40.
30. De Bruijn KM, van Eijck CH. New-onset diabetes after distal pancreatectomy: A systematic review. Ann Surg. 2015;261:854-61.
31. Birnbaum DJ, Gaujoux S, Cherif R, et al. Sporadic nonfunctioning pancreatic neuroendocrine tumors: Prognostic significance of incidental diagnosis. Surgery. 2014;155:13-21.
32. Fischer L, Bergmann F, Schimmack S, et al. Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg. 2014.
33. Cherenfant J, Talamonti MS, Hall CR, et al. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014;156:1504,10; discussion 1510-1.
34. Cusati D, Zhang L, Harmsen WS, et al. Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: Surgical treatment and outcomes. J Am Coll Surg. 2012;215:117,24; discussion 124-5
Artículos relacionados
Instrucciones para citar
Cienfuegos J, Rotellar F, Salguero J, Ruiz-Canela M, Núñez Córdoba J, Sola I, et all. A single institution’s 21-year experience with surgically resected pancreatic neuroendocrine tumors: an analysis of survival and prognostic factors . 4323/2016


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 8621 veces.
Este artículo ha sido descargado 227 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 14/03/2016

Aceptado: 04/08/2016

Prepublicado: 05/10/2016

Publicado: 02/11/2016

Tiempo de revisión del artículo: 139 días

Tiempo de prepublicación: 205 días

Tiempo de edición del artículo: 233 días


Compartir
Este artículo ha sido valorado por 2 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2025 y Creative Commons. Revista Española de Enfermedades Digestivas